Keysight Technologies, Inc. (KEYS)
Industrial Instruments For Measurement, Display, and Control · Healthcare · $59.9B
Intrinsic Value (Consensus)
$69.17
Current Price
$350.29
Margin of Safety
-80.3%
80.3% Above Intrinsic Value
Value: $69
Price: $350
Valuation Model Estimates
Current Price: $350.29
DCF (Discounted Cash Flow)
$351.30
Graham Number
$61.64
Earnings Power Value
$47.67
Relative Value (P/E)
$98.20
Dividend Discount Model
Not applicable
—
Consensus Value
$69.17
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
63
Profitability
18/25
Strength
22/25
Valuation
7/25
Growth
16/25
Financial Health Signals
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $4.91
- EPS (Forward)
- $5.89
- Book Value
- $34.39
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 14.5%
- Debt/Equity
- 43%
- Revenue Growth
- 8.0%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance